PL Jumps 10% on Greece Contract; C-Suite Had Just Sold

NEW YORK, May 10 —

Planet Labs PBC shares rose roughly 10% after the company filed an 8-K with the SEC on May 4 disclosing what multiple financial outlets attributed to a major ESA-backed satellite imagery contract with Greece. The stock most recently traded at $39.04. The problem: in early April, the CEO, CFO, and co-founding Chief Strategy Officer collectively sold $17.86 million of PL on the open market, at prices 10 to 11% below where the stock sits today. Open-market purchases by insiders in the same 90-day window: zero.

A Real Contract Win

The Greece deal arrives as Planet Labs is putting up real numbers. The company generated approximately $310 million in trailing-twelve-month revenue, up 41.1% year-over-year, with a gross margin of 56.2%. Those are not the numbers of a company selling satellites on hope alone. On the earnings line, Planet Labs has beaten analyst EPS consensus estimates in each of its last three reported quarters: actual of $0.00 against an estimate of -$0.04, then -$0.03 against an estimate of -$0.05, and most recently $0.00 against an estimate of -$0.04. Each beat is modest; the direction of travel is not.

Government satellite imagery contracts backed by institutions like ESA tend to run multi-year and renew. European defense and environmental monitoring budgets have been expanding. The ability to deliver near-daily global imagery at commercial scale is not easily duplicated. See the full DCF model and price target →

Before the Pop

On April 2, CFO Ashley Johnson sold two tranches on the open market: 51,460 shares at $34.76 per share, totaling $1.79 million, and 148,540 shares at $35.22 per share, totaling $5.23 million, for a combined $7.02 million out the door in a single day. Four days later, CEO William Spencer Marshall sold 200,000 shares at $35.07, collecting approximately $7.01 million. On the same date, co-founder and CSO Robert Schingler sold 73,683 shares at $35.07, totaling approximately $2.58 million. Board member Ita M. Brennan added $1.24 million in sales on April 15 at $33.91 per share.

In aggregate, per Form 4 filings, insiders recorded $17.86 million in net open-market sales over the 90-day window ending May 10, against zero in open-market purchases. The top three executives all sold within four days of each other.

What the Timing Actually Means

Open-market sales differ from option exercises or scheduled 10b5-1 plan disposals. They represent a deliberate decision to convert equity into cash. Whether these transactions were pre-scheduled under compliance programs is not established in available filings, and executives sell for many legitimate reasons. But when the CEO, CFO, and co-founder all exit within days of each other at similar prices, just ahead of a 10% surge tied to a major contract announcement, the sequence deserves scrutiny.

The executives sold at $34.76 to $35.22. The stock now trades at $39.04. That gap — $3.82 to $4.28 per share — is what the three executives left on the table. It belongs in any honest read of how leadership valued the stock in early April.

What Comes Next

The fundamental case for Planet Labs is not broken. Revenue growth at 41.1%, a 56.2% gross margin, and three consecutive earnings beats point to a business that is performing. The Greece contract confirms that European institutional buyers are paying for commercial satellite coverage.

The question now is how much of that news is already reflected in a stock that moved 10% in a single session. The next checkpoints are contract revenue recognition timing — when the Greece deal actually flows into reported figures — and whether the insider selling cadence resumes or stalls near current levels. A pause in open-market exits near $39 would be encouraging. Another coordinated round would not. The April selling by the CEO, CFO, and CSO doesn't undercut the growth story, but it gives investors reason to be cautious on a stock that has already moved sharply on the news.

Basis Report does not hold positions in securities discussed. This is not investment advice.

Frequently Asked Questions

What did Planet Labs announce on May 10, 2026?

Planet Labs shares jumped roughly 10% on May 10 after multiple outlets reported that a May 4 SEC 8-K filing disclosed a major satellite imagery contract with Greece, reportedly backed by the European Space Agency. Shares rose to $39.04 on the news.

et Labs insiders sell stock before the news?

The CEO, CFO, and co-founding CSO sold a combined $16.6 million in open-market shares between April 2 and April 6, at prices ranging from $34.76 to $35.22, roughly 10 to 11% below where the stock trades after the Greece contract news. Whether those sales were part of prescheduled Rule 10b5-1 trading plans has not been confirmed in the available filings.

How much did Planet Labs insiders sell in 2026?

In the 90 days ending May 10, 2026, Planet Labs insiders recorded $17.86 million in net open-market sales and zero dollars in open-market purchases, per Form 4 filings with the SEC. The sellers included the CEO, CFO, CSO, and a board member.

Is Planet Labs stock a buy after the Greece satellite deal?

The Greece contract strengthens Planet Labs' revenue visibility, and the company reports 41.1% year-over-year revenue growth with a 56.2% gross margin and three consecutive EPS beats. However, at $39.04 the stock trades above the Wall Street analyst consensus target of $35.22, and the coordinated senior insider selling in April raises questions about how much further the stock can run from current levels.

What is Planet Labs' price target?

Basis Report carries a $42.00 price target for Planet Labs based on a full DCF analysis, representing roughly 7.6% upside from the current price of $39.04 following the Greece contract-related gain. The full model is available at Basis Report.